HOME ·

GF CSI HK Innovative Drugs Industry ETF(QDII)

ETF Financing Ranking | GF CSI HK Innovative Drugs Industry ETF(QDII) (513120) had a net financing buy-in of CNY 37.67 million on Jul 23, ranked in the first tier of the entire market
Tags：
GF CSI HK Innovative Drugs Industry ETF(QDII)513120.SHNewTimeSpace
2026-07-24
ETF Financing Ranking | GF CSI HK Innovative Drugs Industry ETF(QDII) (513120) had a net financing buy-in of CNY 57.36 million on Jul 21, ranked in the first tier of the entire market
Tags：
GF CSI HK Innovative Drugs Industry ETF(QDII)513120.SHNewTimeSpace
2026-07-22
ETF Financing Ranking | GF CSI HK Innovative Drugs Industry ETF(QDII) (513120) had a net financing buy-in of CNY 187.2 million on jun 30, ranked in the first tier of the entire market
Tags：
GF CSI HK Innovative Drugs Industry ETF(QDII)513120.SHNewTimeSpace
2026-07-01
ETF Financing Ranking | GF CSI HK Innovative Drugs Industry ETF(QDII) (513120) had a net financing buy-in of CNY 178.74 million on jun 10, ranked first in the entire market-20260610
Tags：
GF CSI HK Innovative Drugs Industry ETF(QDII)513120.SHNewTimeSpace
2026-06-11
ETF Financing Ranking | GF CSI HK Innovative Drugs Industry ETF(QDII) (513120) had a net financing buy-in of CNY 37.51 million, ranked in the first tier of the entire market-20260608
Tags：
GF CSI HK Innovative Drugs Industry ETF(QDII)513120.SH
2026-06-09